Cancer of the Cervix Clinical Trial
Official title:
Integrated Dose Escalation for Advanced, Localized Gynecologic Cancer (The IDEAL - GYN Trial)
The purpose of this study is to determine the maximum tolerated dose of integrated boost radiation therapy when given with concurrent chemotherapy (cisplatin).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00193830 -
High Dose Rate (HDR) Versus Low Dose Rate (LDR) Brachytherapy in Carcinoma Cervix
|
Phase 3 | |
Recruiting |
NCT03403465 -
Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers
|
Phase 2 | |
Completed |
NCT01536392 -
Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation
|
Phase 3 | |
Completed |
NCT00510250 -
A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical Cancer
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05521997 -
Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer
|
Phase 2 | |
Active, not recruiting |
NCT02328872 -
Compass - Randomised Controlled Trial of Primary HPV Testing for Cervical Screening in Australia
|
N/A | |
Recruiting |
NCT00292955 -
Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma
|
Phase 2 | |
Terminated |
NCT03318107 -
Ultrasound and Photoacoustic Imaging for Cervical Cancer
|
N/A | |
Recruiting |
NCT00122746 -
Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients
|
Phase 3 | |
Recruiting |
NCT05975593 -
MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial
|
||
Recruiting |
NCT04868097 -
Predicting Adjuvant Post-operative Radiation Therapy in Patients With Cervical Cancer Stage IB2
|
N/A |